266 related articles for article (PubMed ID: 8413157)
21. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
22. Drugs for tuberculosis.
Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
[No Abstract] [Full Text] [Related]
23. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
24. [Recommendations for the therapy of tuberculosis. (Position: December, 1988)].
Merkel S; Fischer P; Weinecke W
Z Erkr Atmungsorgane; 1989; 173(1):87-96. PubMed ID: 2800620
[No Abstract] [Full Text] [Related]
25. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.
Joint T
Thorax; 1998 Jul; 53(7):536-48. PubMed ID: 9797751
[TBL] [Abstract][Full Text] [Related]
27. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
Laszlo A; Rahman M; Raviglione M; Bustreo F
Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
[TBL] [Abstract][Full Text] [Related]
28. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
30. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
[TBL] [Abstract][Full Text] [Related]
31. [Antitubercular chemotherapy].
Jouveshomme S; Dautzenberg B
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
34. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
35. Treatment of tuberculosis.
Bates JH
Adv Intern Med; 1975; 20():1-21. PubMed ID: 46687
[No Abstract] [Full Text] [Related]
36. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
37. Evaluation of the 3-drug combination, Rifater, versus 4-drug therapy in the ambulatory treatment of tuberculosis in Cape Town.
Macnab MF; Bohmer PD; Seager JR
S Afr Med J; 1994 Jun; 84(6):325-8. PubMed ID: 7740377
[TBL] [Abstract][Full Text] [Related]
38. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
[TBL] [Abstract][Full Text] [Related]
39. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
40. Determinants of the Sympatric Host-Pathogen Relationship in Tuberculosis.
David S; Mateus AR; Duarte EL; Albuquerque J; Portugal C; Sancho L; Lavinha J; Gonçalves G
PLoS One; 2015; 10(11):e0140625. PubMed ID: 26529092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]